Search

everythinglearnresearchcommunity

for

Search:↓

No cure exists for alopecia areata, and treatments are personalized.

Combining microneedling with platelet-rich plasma enhances skin repair and collagen production but may not offer significant extra benefits.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Substances from Chinese medicines show promise for immune support and disease prevention, but the way they are processed affects their effectiveness.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

The document provides detailed care instructions for elderly patients.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

New microneedles deliver drugs through the skin accurately and effectively.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Saw palmetto in hair products might reduce hair loss but can cause side effects.

Collagen VI is crucial for nerve function and affects wound-induced hair regrowth.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

People with Birt-Hogg-Dubé syndrome often have lung problems and delayed diagnosis, and better recognition of CT scan signs could improve diagnosis and management.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

MG53 helps reduce skin damage caused by nitrogen mustard.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Testosterone may influence COVID-19 severity and outcomes.